CardioVascular and Interventional Radiology

, Volume 31, Issue 5, pp 883–888 | Cite as

Chemoembolization (TACE) of Unresectable Intrahepatic Cholangiocarcinoma with Slow-Release Doxorubicin-Eluting Beads: Preliminary Results

  • Camillo Aliberti
  • Giorgio Benea
  • Massimo Tilli
  • Giammaria Fiorentini
Clinical Investigation


The purpose of this study was to evaluate the safety and efficacy of TACE with microspheres preloaded with doxorubicin in unresectable intrahepatic cholangiocarcinoma (UCH). Twenty patients with UCH were observed; 9 refused, preferring other palliative care or chemotherapy, and 11 agreed to be treated with one or more cycles of DC beads loaded with doxorubicin (100–150 mg) in a TACE procedure between February 2006 and September 2007. A total of 29 individual TACE procedures were performed. Follow-up imaging was performed on all patients before, immediately after, and 4 weeks after each TACE procedure to evaluate the response and need for further treatment. Each patient received i.v hydration, antibiotics, and medications against nausea and pain before TACE. Survival rate was calculated using Kaplan-Meier survival curve. A response rate of 100% followed RECIST criteria was observed. Eight of eleven patients are alive, with a median survival of 13 months. TACE was well tolerated by all patients. One patient developed hepatic abscess requiring antibiotic therapy. No evidence of marrow toxicity has been reported. Only one of nine patients treated with chemotherapy or palliative care is alive (with a median survival of 7 months in this group of patients). In conclusion, we suggest that doxorubicin-eluting beads TACE is a feasible and effective treatment in patients with UCH. Survival seems to be clearly prolonged in the treated group with respect to the palliative group. We consider that doxorubicin-eluting beads TACE of 100–150 mg may be an appropriate palliative therapy for these patients. Further studies are warranted to confirm these interesting preliminary data.


Chemoembolization Drug-eluting beads Doxorubicin Cholangiocarcinoma DC Beads 


  1. 1.
    Onles Mj, Erlich R (2004) A review and update on cholangiocarcinoma. Oncology 66(3):167–179CrossRefGoogle Scholar
  2. 2.
    Anderson CD, Wright Pinson C, Berlin J, Chari RS (2004) Diagnosis and treatment of cholangiocarcinoma. Oncologist 9(1):43–57PubMedCrossRefGoogle Scholar
  3. 3.
    Tan JC, Coburn NG, Baxter NN, Kiss A, Law CH (2008) Surgical management of intrahepatic cholangiocarcinoma—a population-based study. Ann Surg Oncol 16(2):600–608Google Scholar
  4. 4.
    Cunningham SC, Choti MA, Bellavance EC, Pawlik TM (2007) Palliation of hepatic tumors. Surg Oncol 16(4):277–291PubMedCrossRefGoogle Scholar
  5. 5.
    Mambrini A, Guglielmi A, Pacetti P, Iacono C, Torri T, Auci A, Nicoli N, Orlandi M, Guadagni S, Fiorentini G, Cantore M (2007) Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study. Anticancer Res 27(4C):3009–3013PubMedGoogle Scholar
  6. 6.
    Cammà C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxì A, Cottone M (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47–54PubMedCrossRefGoogle Scholar
  7. 7.
    Gusani N, Balaa F, Steel J, Geller DA, Marsh JW, Zajko AB, Carr BI, Gamblin TC (2008) Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience. J Gastrointest Surg 12(1):129–137Google Scholar
  8. 8.
    Burger I, Hong K, Schulick R, Georgiades C, Thuluvath P, Choti M, Kamel I, Geschwind JF et al (2005) Transcatheter arterial Chemoembolization in unresectable Cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16(3):353–361PubMedGoogle Scholar
  9. 9.
    Herber S, Otto G, Schneider J, Manzl N, Kummer I, Kanzler S, Schuchmann A, Thies J, Düber C, Pitton M (2007) Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma. CardioVasc Interv Radiol 30(6):1156–1165CrossRefGoogle Scholar
  10. 10.
    Lewis AL, Taylor RR, Hall B et al (2006) Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial chemoembolization. J Vasc Interv Radiol 17:1335–1343PubMedCrossRefGoogle Scholar
  11. 11.
    Varela M, Real IR, Burrel M, Forner A, Sala M, Brunet M, Ayuso C, Castells L, Montañá X, Llovet JM, Bruix J (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy anf doxorubicin pharmacokinetics. J Hepatol 46(3):474–481PubMedCrossRefGoogle Scholar
  12. 12.
    Aliberti C, Tilli M, Benea G, Fiorentini G (2006) Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. Anticancer Res 26:3793–3795PubMedGoogle Scholar
  13. 13.
    Fiorentini G, Aliberti C, Turrisi G, Del Conte A, Rossi S, Benea G, Giovanis P (2007) Intra-arterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study. In vivo 21:1085–1092PubMedGoogle Scholar
  14. 14.
    Golfieri R, Giampalma E, Renzulli M, Galuppi A, Vicenzi L, Galaverni MC, Cappelli A (2006) Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy. In vivo 20(6A):757–760Google Scholar
  15. 15.
    Yonemoto N, Furuse J, Okusaka T, Yamao K, Funakoshi A, Ohkawa S, Boku N, Tanaka K, Nagase M, Saisho H, Sato T (2007) A multi-center retrospective analysis of survival benefits of chemotherapy for unresectable biliary tract cancer. Jpn J Clin Oncol 37(44):843–851Google Scholar
  16. 16.
    Cantore M, Fiorentini G, Mambrini A, Rabbi C, Zamagni D, Carlone N, Manni A, Caudana R, Torri T (2003) Regional combined with systemic chemotherapy in unresectable biliary tract cancers: a phase II study. J Exp Clin Cancer Res 22(Suppl 4):59–64PubMedGoogle Scholar
  17. 17.
    Lewis AL, Adams C, Busby W et al (2006) Comparative in vitro evaluation of microspherical embolisation agents. J Mater Sci Mater Med 17:1193–1204PubMedCrossRefGoogle Scholar
  18. 18.
    Taylor RR, Tang Y, Gonzales MV et al (2007) Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 30(1):7–14PubMedCrossRefGoogle Scholar
  19. 19.
    Lewis AL, Gonzalez MV, Lloyd AW et al (2006) DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17:335–342PubMedGoogle Scholar
  20. 20.
    Hong K, Khwaja A, Liapi E et al (2006) New intraarterial drug delivery system for the treatment of liver cancer: pre-clinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12:2562–2567CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Camillo Aliberti
    • 1
    • 2
  • Giorgio Benea
    • 2
  • Massimo Tilli
    • 2
  • Giammaria Fiorentini
    • 3
  1. 1.Unit of Oncological Diagnostic and Interventional RadiologyDelta HospitalLagosanto, FerraraItaly
  2. 2.Department of RadiologyDelta HospitalFerraraItaly
  3. 3.Department of OncologySan Giuseppe General Hospital, AUSL EmpoliEmpoliItaly

Personalised recommendations